TAMs can induce apoptosis in renal cell carcinoma cells by modulating the PI3K/AKT signaling pathway, leading to mitochondrial dysfunction and activation of both caspase‐9 and caspase‐3 (Zhang et al. 2018). Here, AKT1 is linked to hereditary clear cell renal cell carcinoma.